BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 30139036)

  • 21. Successful treatment of gastric cancer in pregnancy.
    Yoshida M; Matsuda H; Furuya K
    Taiwan J Obstet Gynecol; 2009 Sep; 48(3):282-5. PubMed ID: 19797021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dilemmas in a pregnant woman with myelofibrosis secondary to signet ring adenocarcinoma: a case report.
    Guan P; Chen Z; Zhang L; Pan L
    BMC Cancer; 2017 Oct; 17(1):679. PubMed ID: 29020927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase II study of irinotecan with biweekly, low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFIRI) as first line therapy for patients with recurrent or metastatic gastric cancer.
    Kim BG; Oh SY; Kwon HC; Lee S; Lee DM; Kim SG; Kim DK; Jang JS; Kim MC; Kim SH; Kim HJ
    Am J Clin Oncol; 2010 Jun; 33(3):246-50. PubMed ID: 19770628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safe administration of irinotecan, oxaliplatin and raltitrexed in a DPD-deficient patient with metastatic colon cancer.
    Volk J; Reinke F; van Kuilenburg AB; van Gennip AH; Schlichting C; Ganser A; Schöffski P
    Ann Oncol; 2001 Apr; 12(4):569-71. PubMed ID: 11398894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
    Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L
    BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients.
    Lorenzen S; Blank S; Lordick F; Siewert JR; Ott K
    Ann Surg Oncol; 2012 Jul; 19(7):2119-27. PubMed ID: 22395980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination 5-fluoruracil/cisplatinum versus 5-fluoruracil/leucovorin adjuvant chemotherapy efficacy for R0 gastric resection in locally invasive gastric cancer.
    Yamada S; Ritchim P; Charkrabandhu T; Jongraksat W
    J Med Assoc Thai; 2012 Dec; 95(12):1517-23. PubMed ID: 23390781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Oxaliplatin combined with ELF regimen in the treatment of patients with advanced gastric cancer].
    Lou F; Zhu YH; Pan HM
    Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):75-8. PubMed ID: 19538878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach?
    Heger U; Blank S; Wiecha C; Langer R; Weichert W; Lordick F; Bruckner T; Dobritz M; Burian M; Springfeld C; Grenacher L; Siewert JR; Büchler M; Ott K
    Ann Surg Oncol; 2014 May; 21(5):1739-48. PubMed ID: 24419755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy.
    Nobili S; Checcacci D; Filippelli F; Del Buono S; Mazzocchi V; Mazzei T; Mini E
    J Chemother; 2008 Oct; 20(5):622-31. PubMed ID: 19028627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study).
    Muro K; Boku N; Shimada Y; Tsuji A; Sameshima S; Baba H; Satoh T; Denda T; Ina K; Nishina T; Yamaguchi K; Takiuchi H; Esaki T; Tokunaga S; Kuwano H; Komatsu Y; Watanabe M; Hyodo I; Morita S; Sugihara K
    Lancet Oncol; 2010 Sep; 11(9):853-60. PubMed ID: 20708966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical Resection First for Localized Gastric Adenocarcinoma: Are There Adjuvant Options?
    Elimova E; Ajani JA
    J Clin Oncol; 2015 Oct; 33(28):3085-91. PubMed ID: 26324361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Combination of 5-Fluorouracil and folinic acid--is it still the standard therapy for advanced colorectal carcinoma?].
    Carnaghi C; Zucali P; Garassino I
    Tumori; 2000; 86(5 Suppl 2):S19-25. PubMed ID: 11195298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Two patients with metastatic ovarian tumor (Krukenberg's tumor) of gastric origin who underwent oophorectomy with paraaortic and intrapelvic lymph node dissection].
    Nishioka K; Arai K; Iwasaki Y; Katayanagi S; Takahashi K; Yamaguchi T; Matsumoto H; Miyamoto H; Horiguchi S
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1839-43. PubMed ID: 14619534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase II study of irinotecan, continuous 5-fluorouracil, and leucovorin (FOLFIRI) combination chemotherapy for patients with recurrent or metastatic gastric cancer previously treated with a fluoropyrimidine-based regimen.
    Kim SH; Lee GW; Go SI; Cho SH; Kim HJ; Kim HG; Kang JH
    Am J Clin Oncol; 2010 Dec; 33(6):572-6. PubMed ID: 20042971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) as first-line treatment for advanced gastric cancer.
    Cao W; Yang W; Lou G; Jiang J; Geng M; Xi W; Li H; Ma T; Jin Y
    Anticancer Drugs; 2009 Apr; 20(4):287-93. PubMed ID: 19177020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salvage chemotherapy with the combination of oxaliplatin, leucovorin, and 5-fluorouracil in advanced gastric cancer refractory or intolerant to fluoropyrimidines, platinum, taxanes, and irinotecan.
    Kondoh C; Kadowaki S; Komori A; Narita Y; Taniguchi H; Ura T; Ando M; Muro K
    Gastric Cancer; 2018 Nov; 21(6):1050-1057. PubMed ID: 29658055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis on safety and preliminary efficacy of dose-modified regimen of 5-fluorouracil plus oxaliplatin and irinotecan (FOLFOXIRI) in advanced colorectal cancer].
    Cai Y; Deng R; Hu H; Zhang J; Ling J; Wu Z; Yang L; Li J; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1045-1050. PubMed ID: 30269326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Surgical treatment and prognosis of Borrmann type IIII( gastric cancer involving the whole stomach].
    Dong R; Zhang Z; Zhou Y; Hua Y; Guo J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):185-189. PubMed ID: 29492918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary rectal carcinoma in patients with stage IV resectable disease at diagnosis.
    Pasetto LM; Friso ML; Pucciarelli S; Basso U; Toppan P; Rugge M; Sinigaglia G; Nitti D; Sotti G; Monfardini S
    Anticancer Res; 2007; 27(2):1079-85. PubMed ID: 17465247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.